Abstract 1668: Mutational landscape and pharmacological profiling of a panel of prostate PDX models including hormone-naïve, hormone-sensitive and castrate-resistant prostate cancer specimens

Myriam Lassalle, Claire Béraud, Hervé Lang, Véronique Lindner, Yves Allory, Eric Potiron, Thierry Massfelder, Philippe Lluel, Yolande Misseri

Open source

DOI
10.1158/1538-7445.am2020-1668
Published
2020-08-15
Container
Cancer Research
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1538-7445.am2020-1668,
  title = {Abstract 1668: Mutational landscape and pharmacological profiling of a panel of prostate PDX models including hormone-naïve, hormone-sensitive and castrate-resistant prostate cancer specimens},
  author = {Myriam Lassalle and Claire Béraud and Hervé Lang and Véronique Lindner and Yves Allory and Eric Potiron and Thierry Massfelder and Philippe Lluel and Yolande Misseri},
  year = {2020},
  journal = {Cancer Research},
  doi = {10.1158/1538-7445.am2020-1668},
  url = {https://doi.org/10.1158/1538-7445.am2020-1668}
}

RIS

TY  - JOUR
TI  - Abstract 1668: Mutational landscape and pharmacological profiling of a panel of prostate PDX models including hormone-naïve, hormone-sensitive and castrate-resistant prostate cancer specimens
AU  - Myriam Lassalle
AU  - Claire Béraud
AU  - Hervé Lang
AU  - Véronique Lindner
AU  - Yves Allory
AU  - Eric Potiron
AU  - Thierry Massfelder
AU  - Philippe Lluel
AU  - Yolande Misseri
PY  - 2020
JO  - Cancer Research
DO  - 10.1158/1538-7445.am2020-1668
UR  - https://doi.org/10.1158/1538-7445.am2020-1668
ER  - 

APA

Lassalle, M., Béraud, C., Lang, H., Lindner, V., Allory, Y., Potiron, E., Massfelder, T., Lluel, P., & Misseri, Y. (2020). Abstract 1668: Mutational landscape and pharmacological profiling of a panel of prostate PDX models including hormone-naïve, hormone-sensitive and castrate-resistant prostate cancer specimens. Cancer Research. https://doi.org/10.1158/1538-7445.am2020-1668

Source records